TRISOMY-13 IN ACUTE-LEUKEMIA

被引:36
作者
BAER, MR
BLOOMFIELD, CD
机构
[1] Department of Medicine, Roswell Park Cancer Institute and Division of Oncology, Buffalo, NY
[2] Department of Medicine, State University of New York at Buffalo, Buffalo, NY
关键词
TRISOMY-13; LEUKEMIA; ACUTE; MYELOID; LYMPHOCYTIC;
D O I
10.3109/10428199209053596
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trisomy 13 occurring as a sole cytogenetic abnormality has recently been demonstrated to have adverse prognostic significance in acute leukemia. Trisomy 13 is seen primarily in an older male population, and has been reported in treatment-associated acute leukemia and acute leukemia evolved from myelodysplastic syndromes, as well as in de novo leukemia. The 36 cases of acute leukemia with trisomy 13 reported to date include 26 AML, 6 AUL, 2 ALL and 2 mixed lineage patients. Immunophenotyping studies have demonstrated an undifferentiated phenotype or biphenotypic markers in most cases. Trisomy 13 is associated with a low complete remission rate and with brief remission duration. The role of the additional copy of chromosome 13 in the pathogenesis of these cases of acute leukemia and the gene(s) of importance on chromosome 13 are yet to be determined. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 26 条
  • [1] Baer M.R., Bloomfield C.D., The clinical use of cytogenetics in acute leukemia, Annals of Medicine, 23, pp. 117-119, (1991)
  • [2] Mitelman F., Catalog of Chromosome Aberrations in Cancer, (1991)
  • [3] Hsu L.Y.F., Papenhausen P., Greenberg M.L., Hirschhorn K., Trisomy D in bone marrow cells in a patient with chronic myelogenous leukemia, Acta Haematologica, 52, pp. 61-62, (1974)
  • [4] Muir P.D., Occomore M.A., Thornley B., Singh S., Gunz F.W., The value of chromosome banding methods in the study of adult acute leukaemia, Pathology, 9, pp. 323-330, (1977)
  • [5] Golomb H.M., Vardiman J.W., Rowley J.D., Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia, New England Journal of Medicine, 299, pp. 613-619, (1978)
  • [6] Hsu L.Y.F., Greenberg M.L., Kohan S., Wittman R., Trisomy 13 in bone marrow cells in acute myelocytic leukemia and myelofibrosis, Clinical Genetics, 15, pp. 327-331, (1979)
  • [7] Saxne T., Turesson I., Wollheim F.A., Preleukemic syndrome simulating SLE: A case report, Acta Medica Scandinavica, 212, pp. 421-424, (1982)
  • [8] Bernard P., Reiffers J., Lacombe F., Dachary D., Boisseau M.R., Broustet A., A stage classification for prognosis in adult myelogenous leukemia based upon patients' age, bone marrow karyotype and clinical features, Scandinavian Journal of Haemalology, 32, pp. 429-440, (1984)
  • [9] Arthur D.C., Bloomfield C.D., Banded chromosome analysis in patients with treatment-associated acute nonlymphocytic leukemia, Cancer Genetics and Cytogenetics, 12, pp. 189-199, (1984)
  • [10] Morris C.M., Fitzgerald P.H., An evaluation of high resolution chromosome banding of hematologic cells by methotrexate synchronization and thymidine release, Cancer Genetics and Cytogenetics, 14, pp. 275-284, (1985)